German specialty drugmaker Neuraxpharm has licensed commercial rights in Europe to a wearable device developed by Spanish start-up mjn-neuro that is designed to warn a person with epilepsy
Young adults with depression have been treated effectively with a cognitive behavioural therapy (CBT) course – delivered via text message – in a pilot study conducted by researchers in the
And the LIVE coverage continues as we head into Day Two... This day is set to hold even more points of interest, with the demonstration ‘CX innovation: building experiences that wo
Hard on the heels of the official launch of its digital disease management platform, Aptar Pharma has secured a partnership with Italian drugmaker Chiesi to deploy it in support of patients
Medtech giant Beckton Dickinson (BD) has signed a deal with France's Biocorp to use the latter's near-field communication (NFC) tags in injectable devices.